Langerhans cells and immature dendritic cells as model systems for screening of skin sensitizers.

Langerhans cells are the most potent antigen-presenting cells in the skin and play a critical role in the induction of contact allergy. Research on the phenotypical and functional changes of LCs occurring after application of skin sensitizers indicated their use as an in vitro model for the screening of chemicals. In the present investigations, LCs from human skin explants served as the test system. The application of this cell system has been aggravated by the difficulty in isolating sufficient numbers of live LCs from skin. This disadvantage was overcome by the culture of immature dendritic cells from peripheral mononuclear blood cells. These cells can serve as a replacement for LCs as they bind haptens and show phenotypical and functional changes similar to LCs. The sensitizers NiSO(4), dinitrochlorobenzene, 2,4,6-trinitrobenzene sulfonic acid, alpha-hexylcinnamaldehyde and eugenol were applied. Both the expression of surface markers and the induction of intracellular interleukin-1 beta (IL-1 beta) were analyzed. No clear-cut results could be established for intracellular cytokine production, only NiSO(4) induced a remarkable number of IL-1 beta-positive cells. However, all skin sensitizers caused an up-regulation of the co-stimulatory molecule CD86, of intercellular adhesion molecule CD54 and of the HLA-DR antigen. The irritant sodium dodecyl sulfate (SDS) and the vehicle dimethyl sulfoxide (DMSO) had no effect.

[1]  M. Zakin,et al.  Detection of immunologically active zones in equine growth hormone , 1976, European journal of immunology.

[2]  J. Knop,et al.  Contact allergens modulate the expression of MHC class II molecules on murine epidermal Langerhans cells by endocytotic mechanisms. , 1992, The Journal of investigative dermatology.

[3]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[4]  I. Kimber,et al.  Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor α , 1997, Archives of Dermatological Research.

[5]  A. Cordier,et al.  Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[6]  H. Tuschl,et al.  The expression of surface markers on dendritic cells as indicators for the sensitizing potential of chemicals. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.

[7]  U. Hoppe,et al.  Phenotype and alloactivating capacity of dendritic cells generated under different culture conditions from human peripheral blood. , 1995, Advances in experimental medicine and biology.

[8]  H. Tagami,et al.  In vitro treatment of human transforming growth factor‐β1‐treated monocyte‐derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction , 2000, Immunology.

[9]  J. Banchereau,et al.  Dendritic Cells in Fundamental and Clinical Immunology , 2012, Advances in Experimental Medicine and Biology.

[10]  A Cordier,et al.  Early changes in murine epidermal cell phenotype by contact sensitizers. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  Marianne Ekman,et al.  Differentiation of human dendritic cells from monocytes in vitro , 1997, European journal of immunology.

[12]  G. Schuler,et al.  Expression of maturation-/migration-related molecules on human dendritic cells from blood and skin. , 1998, Immunobiology.

[13]  S. Aiba,et al.  Phenotypic and functional characteristics of in vivo-activated Langerhans cells. , 1990, Journal of immunology.

[14]  A. Enk,et al.  Early molecular events in the induction phase of contact sensitivity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Jäger,et al.  In vitro model for contact sensitization: II. Induction of IL-1beta mRNA in human blood-derived dendritic cells by contact sensitizers. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.

[16]  S. Aiba,et al.  Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co‐stimulatory molecules , 1997, European journal of immunology.

[17]  I. Kimber,et al.  REVIEWCytokines and chemokines in the initiation and regulation of epidermal Langerhans cell mobilization , 2000, The British journal of dermatology.

[18]  G. Schuler,et al.  Production and properties of large numbers of dendritic cells from human blood. , 1995, Advances in experimental medicine and biology.

[19]  I Kimber,et al.  Investigation of induced changes in interleukin 1beta mRNA expression by cultured human dendritic cells as an in vitro approach to skin sensitization testing. , 2000, Toxicology in vitro : an international journal published in association with BIBRA.